Anders Wittrup Kristensen

DealPotential is a Swedish Ai, data & research company working on a global scale, offering the next generation of an Investment Intelligence platform that helps Venture Capital and Private Equity firms to find, analyze and evaluate Companies, Markets, and investments. Augmented Analytics - Get Actionable Insights Faster and Easier! We eat, breath and sleep data. Its in our DNA. We aggregate data from more than 21,000 sources with over 200,000 data points. But too much data can be overwhelming. We want to simplify advanced data and give you understandable information that immediately can be used to make critical business decisions. By applying our unique metrics, algorithms, and AI technology combined with Machine Learning and Natural Language Generation, we can deliver understandable data that puts you way ahead of your competitors!

Darcy Partners is a technology scouting and innovation advisory firm serving the energy industry. Our member companies rely on us to identify and validate critical technology solutions and to help them benchmark and improve their operations and their overall innovation ecosystems. Our team includes investors, scientists, consultants, and energy sector veterans who have come together as a one-stop-shop for innovation in the energy industry.

DealPotential is a Swedish Ai, data & research company working on a global scale, offering the next generation of an Investment Intelligence platform that helps Venture Capital and Private Equity firms to find, analyze and evaluate Companies, Markets, and investments. Augmented Analytics - Get Actionable Insights Faster and Easier! We eat, breath and sleep data. Its in our DNA. We aggregate data from more than 21,000 sources with over 200,000 data points. But too much data can be overwhelming. We want to simplify advanced data and give you understandable information that immediately can be used to make critical business decisions. By applying our unique metrics, algorithms, and AI technology combined with Machine Learning and Natural Language Generation, we can deliver understandable data that puts you way ahead of your competitors!

Plug and Play is a global innovation platform founded in Silicon Valley in 2006. We connect the people and organizations that drive technology forward, and turn those connections into real business outcomes. We run accelerator programs, facilitate corporate-startup pilots, invest in early-stage companies, and help governments and institutions build innovation ecosystems. Our network includes corporations, startups, investors, universities, and mentors across more than 20 industries and 60 locations worldwide. Since inception, weve accelerated thousands of startups and invested in over 2,500 companies. Our portfolio includes PayPal, Dropbox, LendingClub, Honey, and N26. Industries we work in: Advanced Manufacturing · Aerospace & Defense · Agtech · Animal Health · Brand & Retail · Crypto & Digital Assets · Deeptech · Energy · Enterprise & AI · Fintech · Food & Beverage · Health · Insurtech · Lifetech · Maritime · Media & Advertising · Medtech · Mobility & Physical AI · New Materials & Packaging · Real Estate & Construction · Semiconductors · Smart Cities · Sportstech · Supply Chain · Sustainability · Travel & Hospitality Where we operate: Americas: Silicon Valley · New York · Los Angeles · Washington D.C. · Detroit · Seattle · São Paulo · Alberta Europe: London · Munich · Stuttgart · Paris · Amsterdam · Barcelona · Madrid · Milan · Turin · Gothenburg · Vienna · Istanbul · Antwerp · Vilnius · Tirana · Yerevan · Tbilisi · Limassol · Tashkent Middle East & Africa: Riyadh · Abu Dhabi · Cairo Asia-Pacific: Tokyo · Osaka · Kyoto · Singapore · Seoul · Shanghai · Beijing · Shenzhen · Jakarta · Kuala Lumpur · Phnom Penh · GIFT City

We invest in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain.

Tabula Rasa Ventures (TRV) is a pioneering investment firm building the future of human health. With a vision centered on a holistic, preventative, personalized, and democratized approach to healthcare, TRV is deeply committed to investments grounded in rigorous scientific and clinical data. TRV Fund I specifically targets pre-seed and seed-stage companies that are pioneering in the development of evidence-based therapeutic interventions, robust healthcare infrastructure, and cutting-edge medical technologies, shaping the future landscape of healthcare.